Incoming information from the retina is channeled into two pathways in the brain's visual system: one that's responsible for ...

Novartis builds case for Xolair follow-up ligelizumab in chronic spontaneous urticaria or CSU, as phase 3 trials head for data readouts later this year ...

AstraZeneca is celebrating two new approvals for cancer therapies Imfinzi and Enhertu in the EU as it faces the threat of increased competition to its top seller Tagrisso. Daiichi Sankyo-partnered ...